Further Standardization of Broth Microdilution Methodology for In Vitro Susceptibility Testing of Caspofungin against Candida Species by Use of an International Collection of More than 3,000 Clinical Isolates

Ítems similars

• Wild-Type MIC Distributions and Epidemiological Cutoff Values for Posaconazole and Voriconazole and Candida spp. as Determined by 24-Hour CLSI Broth Microdilution
  per: Pfaller, M. A., et al.
  Publicat: (2011)
• In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods
  per: Diekema, D. J., et al.
  Publicat: (2009)
• In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method
  per: Pfaller, M. A., et al.
  Publicat: (2009)
• Caspofungin Activity against Clinical Isolates of Fluconazole-Resistant Candida
  per: Pfaller, Michael A., et al.
  Publicat: (2003)
• Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Voriconazole among 13,338 Clinical Isolates of Candida spp. Tested by Clinical and Laboratory Standards Institute-Recommended Broth Microdilution Methods
  per: Pfaller, M. A., et al.
  Publicat: (2007)